期刊文献+

HLA衍生肽对大鼠脾细胞增殖功能及HO-1活性的影响 被引量:3

Effects of HLA-derived peptide on proliferation and heme oxygenase-1 activity of rat spleen cells
下载PDF
导出
摘要 目的 观察一种新型组织相容性白细胞抗原 (histocompatibilityleukocyteantigen ,HLA)衍生肽 (RDP12 5 8)的免疫抑制功能并探讨其机制。方法 人工固相合成一种HLA衍生肽 (RDP12 5 8) ,用 3 H TdR法观察其在体外对大鼠脾细胞增殖反应的影响 ,以酶化学法观察其对脾细胞血红素氧合酶 1(hemeoxygenase 1,HO 1)活性的影响。结果 RDP12 5 8可显著抑制淋巴细胞转化及MLR的增殖反应 ;该肽体外降低HO活性呈现出剂量依赖性。结论 RDP12 5 8能够显著抑制大鼠脾细胞经丝裂原或同种抗原刺激引起的增殖反应 ,这种作用可能是通过影响HO Objective To investigate the immunosuppression function of a novel HLA derived peptide, RDP1258, and its mechanisms. Methods A peptide derived from HLA, RDP1258, was chemically synthesized by artificial solid phase synthesis. Effects of the peptide on alloreactive cytotoxic activity of rat spleen cells and heme oxygenase 1 (HO 1) activity were observed using 3H TdR method and enzyme chemistry method, respectively. Results The synthetic HLA derived peptide could obviously inhibit the proliferation of rat spleen cells and mixed lymphocyte reaction, and reduce HO activity in a dose dependent manner in vitro . Conclusion RDP1258 can significantly inhibit the proliferation of rat spleen cells induced by mitogen and isoantigen possibly by means of affecting HO 1 activity.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2004年第4期314-316,共3页 Journal of Third Military Medical University
基金 国家新药基金资助项目 ( 1999A0 0 2 )~~
关键词 HLA衍生肽 混合淋巴细胞培养 血红素氧化酶-1 HLA derived peptide mixed lymphocyte reaction heme oxygenase 1
  • 相关文献

参考文献1

二级参考文献5

  • 1汪泽厚,免疫学杂志,1999年,15卷,1期,22页
  • 2Woo J,Trans plantation,1995年,60卷,10期,1156页
  • 3Nisco S,J Immunol,1994年,152卷,3786页
  • 4赵桐茂,HLA分型原理和应用,1984年,275页
  • 5陈嘉华,中华微生物学和免疫学杂志,1983年,3卷,4期,231页

共引文献9

同被引文献30

  • 1张坤,余佩武,高朋芬,汪灏,刘伟,饶云.胃癌患者外周血DCs细胞表型变化研究[J].第三军医大学学报,2004,26(13):1207-1209. 被引量:5
  • 2吴淼,余佩武,王自强,赵永亮,雷晓,曾冬竹,朱自满.反义B7-H1位置特异性腺病毒载体的构建与鉴定[J].第三军医大学学报,2006,28(5):387-390. 被引量:2
  • 3Nisco S, Vriens P, Hoyt G, et al. Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A[J]. J Immunol, 1994, 152(8): 3786-3792.
  • 4Hanaway M J, Geissler E K, Wang J, et al. Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model[J]. Transplantation, 1996, 61(8): 1222-1228.
  • 5Cuturi M C, Christoph F, Woo J, et al. RDP1258, a new retionally designed immunosuppressive peptide, prolongs allograft survival in rats analysis of its mechanism of action [J]. Mol Med, 1999, 5(12): 820-832.
  • 6Parham P, Clayberger C, Zorn S L, et al. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the α2 domain of HLA-A2 [J]. Nature, 1987, 325(6105): 625-628.
  • 7Giral M, Cuturi M C, Nguyen J M, et al. Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA-derived peptide [J]. Transplantation, 1997, 63(7): 1004-1011.
  • 8Grassy G, Calas B, Yasri A, et al. Computer-assisted rational design of immunosuppressive compounds [J]. Nat Biotechnol, 1998, 16(8): 748-752.
  • 9Iyer S, Woo J, Cornejo M C, et al. Characterization and biological significance of immunosuppressive peptide D2702.75-84(E→V) binding protein: Isolation of heme oxygenase-1[J]. J Biol Chem, 1998, 273(5): 2692-2697.
  • 10Coito A, Shaw G, Li J, et al. Selectin-mediated interactions regulate cytokine networks and macrophage heme oxygenase-1 induction in cardiac allograft recipients[J]. Lab Invest, 2002, 82 (1): 61-70.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部